Masters Capital Management LLC Bristol Myers Squibb CO Call Options Transaction History

Masters Capital Management LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $34.5 Million - $38.2 Million	-600,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $16.4 Million - $19.2 Million	300,000 Added 100.0%	600,000 $35.3 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $13.9 Million - $20.2 Million	300,000 New	300,000 $16.7 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $74.5 Million - $96.6 Million	-1,527,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $27.6 Million - $31.1 Million	500,000 Added 48.69%	1,527,000 $94.8 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $252,650 - $314,900	-5,000 Reduced 0.48%	1,027,000 $56.8 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $1.92 Million - $2.21 Million	32,000 Added 3.2%	1,032,000 $65.3 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $36.6 Million - $39.9 Million	610,000 Added 156.41%	1,000,000 $61.3 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $21.5 Million - $24.9 Million	390,000	390,000 $24.9 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Masters Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Masters Capital Management LLC with notifications on news.